BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19288298)

  • 41. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
    Xu FH; Zhang Q
    Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique.
    Lee S; Kim MS; Kim JS; Park HJ; Woo JS; Lee BC; Hwang SJ
    J Microencapsul; 2006 Nov; 23(7):741-9. PubMed ID: 17123918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method.
    Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y
    J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency.
    Mok H; Park JW; Park TG
    Pharm Res; 2007 Dec; 24(12):2263-9. PubMed ID: 17929147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling.
    Busatto C; Pesoa J; Helbling I; Luna J; Estenoz D
    Int J Pharm; 2018 Jan; 536(1):360-369. PubMed ID: 29217474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and statistical optimization of novel double-incorporated PLA-PLGA microparticles within an alginate-pectinate platform for the delivery of nicotine.
    Singh N; Seedat F; Pillay V; Sweet JL; Danckwerts MP
    J Microencapsul; 2006 Mar; 23(2):153-67. PubMed ID: 16754372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In-vitro release profile.
    Ramirez L; Pastoriza P; Herrero-Vanrell R
    J Microencapsul; 1999; 16(1):105-15. PubMed ID: 9972507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol): characterization and application to entrapment into biodegradable microspheres.
    Morita T; Horikiri Y; Suzuki T; Yoshino H
    Int J Pharm; 2001 May; 219(1-2):127-37. PubMed ID: 11337173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres.
    Cirpanli Y; Unlü N; Caliş S; Hincal AA
    J Microencapsul; 2005 Dec; 22(8):877-89. PubMed ID: 16423759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erosion of biodegradable block copolymers made of poly(D,L-lactic acid) and poly(ethylene glycol).
    von Burkersroda F; Gref R; Göpferich A
    Biomaterials; 1997 Dec; 18(24):1599-607. PubMed ID: 9613807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release.
    Wu J; Zhao X; Yeung KW; To MK
    Curr Drug Deliv; 2016; 13(5):720-9. PubMed ID: 26638974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide).
    Cho KY; Choi SH; Kim CH; Nam YS; Park TG; Park JK
    J Control Release; 2001 Oct; 76(3):275-84. PubMed ID: 11578742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.